Brokerages Set UiPath Inc. (NYSE:PATH) Target Price at $17.47

Shares of UiPath Inc. (NYSE:PATH) have received an average recommendation of “Hold” from the eighteen research firms that are currently covering the stock, MarketBeat reports. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $17.47.

PATH has been the topic of several research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research note on Wednesday, October 23rd. Wells Fargo & Company dropped their price target on UiPath from $15.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. TD Cowen decreased their price objective on UiPath from $17.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, September 6th. Bank of America raised their target price on shares of UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, DA Davidson upped their price target on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Friday, September 6th.

UiPath Trading Down 0.8 %

UiPath stock opened at $12.60 on Friday. The firm has a market capitalization of $6.93 billion, a P/E ratio of -63.00 and a beta of 0.88. The business has a 50-day moving average of $12.53 and a 200-day moving average of $13.92. UiPath has a 1 year low of $10.37 and a 1 year high of $27.87.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $316.00 million during the quarter, compared to analysts’ expectations of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.09) earnings per share. Research analysts anticipate that UiPath will post -0.23 EPS for the current fiscal year.

Insider Activity

In related news, CFO Ashim Gupta sold 47,671 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at approximately $10,258,498.19. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 22.37% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On UiPath

Hedge funds have recently bought and sold shares of the company. Future Financial Wealth Managment LLC acquired a new stake in UiPath during the 3rd quarter valued at $26,000. JTC Employer Solutions Trustee Ltd acquired a new stake in shares of UiPath during the 3rd quarter worth about $26,000. ORG Partners LLC boosted its holdings in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after buying an additional 1,112 shares during the period. Hantz Financial Services Inc. acquired a new position in UiPath in the 2nd quarter valued at about $28,000. Finally, Redwood Wealth Management Group LLC bought a new position in UiPath in the 2nd quarter valued at about $43,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.